Exploration of nitrotyrosine-containing proteins and peptides by antibody-based enrichment strategies.

Immunoaffinity Nitrotyrosine Oxidative stress Peroxynitrite Post-translational modifications Protein kinase

Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
09 Feb 2024
Historique:
received: 21 10 2023
revised: 09 01 2024
accepted: 08 02 2024
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 11 2 2024
Statut: aheadofprint

Résumé

Nitrotyrosine, or 3-nitrotyrosine, is an oxidative post-translational modification induced by reactive nitrogen species. Although nitrotyrosine is considered as a marker of oxidative stress and has been associated with inflammation, neurodegeneration, cardiovascular disease and cancer, identification of nitrotyrosine-modified proteins remains challenging owing to its low stoichiometric levels in biological samples. To facilitate a comprehensive analysis of proteins and peptides containing nitrotyrosine, we optimized an immunoprecipitation-based enrichment workflow using a cell line model. The identification of proteins and peptides containing nitrotyrosine residues was carried out after peroxynitrite treatment of cell lysates, which generated modified nitrotyrosine residues on susceptible sites on proteins. We evaluated the efficacy of enriching nitrotyrosine-modified proteins and peptides by employing four different commercially available monoclonal antibodies directed against nitrotyrosine. LC-MS/MS analysis resulted in the identification of 1,377 and 1,624 nitrotyrosine-containing peptides from protein- and peptide-based enrichment experiments, respectively. Although the yield of nitrotyrosine-containing peptides was higher in experiments where peptides rather than proteins were enriched, we found a substantial proportion (37-65%) of identified nitrotyrosine-containing peptides contained nitrotyrosine at the N-terminus. However, in protein-based immunoprecipitation <9% of nitrotyrosine-containing peptides had nitrotyrosine modification at the N-terminus of the peptide. Overall, our study resulted in the identification of 2,603 nitrotyrosine-containing peptides of which >2,000 have not previously been reported. We synthesized 101 novel nitrotyrosine-containing peptides identified in our analysis and analyzed them by LC-MS/MS to validate our findings. We have confirmed the validity of 70% of these peptides, as they demonstrated a similarity score exceeding 0.7 when compared to peptides identified through experimental methods. Finally, we also validated presence of nitrotyrosine modification on PKM and EF2 proteins in peroxynitrite-treated samples by immunoblot analysis. The large catalog presented in this study along with the workflow should facilitate investigation of nitrotyrosine as an oxidative modification in a variety of settings in greater detail.

Identifiants

pubmed: 38342410
pii: S1535-9476(24)00023-9
doi: 10.1016/j.mcpro.2024.100733
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100733

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All the authors declare that they have no conflict of interest with the contents of this article.

Auteurs

Firdous A Bhat (FA)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Kiran K Mangalaparthi (KK)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Husheng Ding (H)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Anu Jain (A)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Joel-Sean Hsu (JS)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.

Jane A Peterson (JA)

Proteomics Core, Mayo Clinic, Rochester, MN 55905, USA.

Roman M Zenka (RM)

Proteomics Core, Mayo Clinic, Rochester, MN 55905, USA.

Dong-Gi Mun (DG)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Richard K Kandasamy (RK)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Akhilesh Pandey (A)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA; Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India; Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: pandey.akhilesh@mayo.edu.

Classifications MeSH